External validity

MG Findley, K Kikuta, M Denly - Annual Review of Political …, 2021 - annualreviews.org
External validity captures the extent to which inferences drawn from a given study's sample
apply to a broader population or other target populations. Social scientists frequently invoke …

Designing difference in difference studies: best practices for public health policy research

C Wing, K Simon… - Annual review of public …, 2018 - annualreviews.org
The difference in difference (DID) design is a quasi-experimental research design that
researchers often use to study causal relationships in public health settings where …

Post-2020 biodiversity framework challenged by cropland expansion in protected areas

Z Meng, J Dong, EC Ellis, G Metternicht, Y Qin… - Nature …, 2023 - nature.com
Protected areas (PAs) are essential for biodiversity conservation but are threatened by
cropland expansion. Recent studies have only reported global cropland expansion in large …

[PDF][PDF] Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes

L Zhu, ZG She, X Cheng, JJ Qin, XJ Zhang, J Cai, F Lei… - Cell metabolism, 2020 - cell.com
Summary Type 2 diabetes (T2D) is a major comorbidity of COVID-19. However, the impact of
blood glucose (BG) control on the degree of required medical interventions and on mortality …

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

N Biran, A Ip, J Ahn, RC Go, S Wang… - The Lancet …, 2020 - thelancet.com
Background Tocilizumab, a monoclonal antibody directed against the interleukin-6 receptor,
has been proposed to mitigate the cytokine storm syndrome associated with severe COVID …

Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA. 4 and BA. 5 in Colorado, USA: a retrospective …

NR Aggarwal, KC Molina, LE Beaty… - The Lancet Infectious …, 2023 - thelancet.com
Background Nirmatrelvir is a protease inhibitor with in-vitro activity against SARS-CoV-2,
and ritonavir-boosted nirmatrelvir can reduce the risk of progression to severe COVID-19 …

The mental health of frontline and non-frontline medical workers during the coronavirus disease 2019 (COVID-19) outbreak in China: A case-control study

Q Cai, H Feng, J Huang, M Wang, Q Wang, X Lu… - Journal of affective …, 2020 - Elsevier
Background and objective Coronavirus disease 2019 (COVID-19) is a new infectious
disease with high transmissibility and morbidity. It has caused substantial mental distress to …

[PDF][PDF] The polygenic and monogenic basis of blood traits and diseases

D Vuckovic, EL Bao, P Akbari, CA Lareau, A Mousas… - Cell, 2020 - cell.com
Blood cells play essential roles in human health, underpinning physiological processes
such as immunity, oxygen transport, and clotting, which when perturbed cause a significant …

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

J Stebbing, G Sánchez Nievas, M Falcone… - Science …, 2021 - science.org
Using AI, we identified baricitinib as having antiviral and anticytokine efficacy. We now show
a 71%(95% CI 0.15 to 0.58) mortality benefit in 83 patients with moderate-severe SARS-CoV …

[HTML][HTML] Balance diagnostics after propensity score matching

Z Zhang, HJ Kim, G Lonjon, Y Zhu - Annals of translational …, 2019 - ncbi.nlm.nih.gov
Propensity score matching (PSM) is a popular method in clinical researches to create a
balanced covariate distribution between treated and untreated groups. However, the …